[ESPR] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
02-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -13.90%
YoY- -83.82%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 24,329 18,818 18,980 18,841 18,836 15,401 14,409 41.84%
PBT -61,719 -55,487 -55,117 -66,324 -56,731 -65,119 -69,386 -7.51%
Tax 27,501 12,974 13,494 13,948 13,742 13,430 13,667 59.45%
NP -89,220 -68,461 -68,611 -80,272 -70,473 -65,119 -69,386 18.26%
Tax Rate - - - - - - - -
Total Cost 113,549 87,279 87,591 99,113 89,309 80,520 83,795 22.47%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -366.72 -363.81 -361.49 -426.05 -374.14 -422.82 -481.55 -16.62%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -1.14 -0.93 -1.01 -1.27 -1.16 -1.77 -2.62 -42.60%
EPS Diluted -1.14 -0.93 -1.01 -1.27 -1.16 -1.77 -2.62 -42.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.